Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Roche HER2-ADC Enmetrastuzumab has been approved for marketing in China

En-CPhI.CNJanuary 19, 2020

Tag: china , Roche , Breast Cancer , antibody , HER2-ADC

PharmaSources Customer Service